This inventor holds 31 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Immunogenic Compositions. Top assignees: Baxter International Inc., National Research Council of Canada, Wellstat Vaccines, LLC. Active years: 1993-2023.
Location History:
- Ottawa, CA (1993 - 1999)
- Beltsville, MD (US) (1999)
- Bethesda East, MD (US) (2002 - 2003)
- Laurel, MD (US) (1998 - 2008)
- Bethesda, MD (US) (2001 - 2023)
Company Filing History:
11 out of 2,531 
8 out of 1,039 
7 out of 7 
Years Active: 1993-2023
Areas of Expertise:
Title: **Francis Michon: Innovator in Immunogenic Compositions and Fungal Infection Treatments**
Introduction
Francis Michon is a notable inventor based in Bethesda, MD, who has made significant contributions to the field of immunology. With a total of 31 patents to his name, Michon's work primarily focuses on innovative technologies aimed at the prevention and treatment of nosocomial infections.
Latest Patents
Among his latest patents are groundbreaking inventions that include immunogenic compositions for the prevention and treatment of hospital-acquired infections. One of his remarkable patents details a compound consisting of polysaccharide moieties characterized by the formula β(1→4)-[GlcNH—R]-2,5-anhydromannose. This compound features positive integers ranging from 3 to 500, wherein R may be hydrogen or an acyl group. The compound is produced through a detailed process: first, chitosan is reacted with an acylating agent to achieve partial N-acylation. Then, the modified chitin/chitosan mixed polymer is treated with a deaminating agent to cleave it at the unacylated chitosan moieties. This innovative compound aims to provide immunization against fungal infections, focusing on the development of antibodies specific to the compound for protective purposes.
Career Highlights
Francis Michon has had a fruitful career, notably contributing to prominent organizations such as Baxter International Inc. and the National Research Council of Canada. His work has not only advanced scientific understanding but has also provided practical solutions to critical health issues, particularly in the field of immunology.
Collaborations
Throughout his career, Michon has collaborated with esteemed colleagues including Harold J. Jennings and Samuel J. Wohlstadter. These professional relationships have fostered innovation and have been integral to the successful development of Michon's patent portfolio.
Conclusion
In conclusion, Francis Michon stands out as a prolific innovator whose patents reflect a deep commitment to improving medical science. His latest inventions underscore the exciting possibilities in combating nosocomial infections and highlight his essential role in advancing immunological research. Through his collaborations and career journey, Michon continues to inspire future innovations in the field.